Individualized in vitro and in silico methods for predicting in vivo performance of enteric-coated tablets containing a narrow therapeutic index drug

2019 ◽  
Vol 135 ◽  
pp. 13-24 ◽  
Author(s):  
Frank Karkossa ◽  
Sandra Klein
Molecules ◽  
2021 ◽  
Vol 26 (9) ◽  
pp. 2505
Author(s):  
Raheem Remtulla ◽  
Sanjoy Kumar Das ◽  
Leonard A. Levin

Phosphine-borane complexes are novel chemical entities with preclinical efficacy in neuronal and ophthalmic disease models. In vitro and in vivo studies showed that the metabolites of these compounds are capable of cleaving disulfide bonds implicated in the downstream effects of axonal injury. A difficulty in using standard in silico methods for studying these drugs is that most computational tools are not designed for borane-containing compounds. Using in silico and machine learning methodologies, the absorption-distribution properties of these unique compounds were assessed. Features examined with in silico methods included cellular permeability, octanol-water partition coefficient, blood-brain barrier permeability, oral absorption and serum protein binding. The resultant neural networks demonstrated an appropriate level of accuracy and were comparable to existing in silico methodologies. Specifically, they were able to reliably predict pharmacokinetic features of known boron-containing compounds. These methods predicted that phosphine-borane compounds and their metabolites meet the necessary pharmacokinetic features for orally active drug candidates. This study showed that the combination of standard in silico predictive and machine learning models with neural networks is effective in predicting pharmacokinetic features of novel boron-containing compounds as neuroprotective drugs.


Shock ◽  
2020 ◽  
Vol 53 (5) ◽  
pp. 605-615
Author(s):  
Joseph E. Rupert ◽  
Daenique H. A. Jengelley ◽  
Teresa A. Zimmers

2018 ◽  
Vol 25 (28) ◽  
pp. 3286-3318 ◽  
Author(s):  
Kaja Bergant ◽  
Matej Janezic ◽  
Andrej Perdih

Background: The family of DNA topoisomerases comprises a group of enzymes that catalyse the induction of topological changes to DNA. These enzymes play a role in the cell replication machinery and are, therefore, important targets for anticancer drugs - with human DNA topoisomerase IIα being one of the most prominent. Active compounds targeting this enzyme are classified into two groups with diverse mechanisms of action: DNA poisons act by stabilizing a covalent cleavage complex between DNA and the topoisomerase enzyme, transforming it into a cellular toxin, while the second diverse group of catalytic inhibitors, provides novel inhibition avenues for tackling this enzyme due to frequent occurrence of side effects observed during the DNA poison therapy. Methods: Based on a comprehensive literature search we present an overview of available bioassays and in silico methods in the identification of human DNA topoisomerase IIα inhibitors. Results and Conclusion: A comprehensive outline of the available methods and approaches that explore in detail the in vitro mechanistic and functional aspects of the topoisomerase IIα inhibition of both topo IIα inhibitor groups is presented. The utilized in vitro cell-based assays and in vivo studies to further explore the validated topo IIα inhibitors in subsequent preclinical stages of the drug discovery are discussed. The potential of in silico methods in topoisomerase IIα inhibitor discovery is outlined. A list of practical guidelines was compiled to aid new as well experienced researchers in how to optimally approach the design of targeted inhibitors and validation in the preclinical drug development stages.


Author(s):  
Sachin M. Mendhi ◽  
Manoj S. Ghoti ◽  
Mandar A. Thool ◽  
Rinkesh M. Tekade

This article deals with the in – silico techniques for predicting the toxicity of chemical compounds. Toxicology is the branch of biology that deals with the study of adverse effect of chemical substances on the living organisms and the practice of treating and preventing such adverse effects. Predicting toxicity of a new drug to be produced is the first aim of preclinical trials. It is achieved by in-silico methods. There are several in - silico technique softwares which are used for the prediction of ADME and hence toxicity of drugs. In – silico methods involves the use of various softwares to calculate and then predict the toxicity of a compound by first determining its structural and pharmacokinetic and pharmacodynamic properties and then it correlates this information with already existing drugs and molecules and thus gives us conclusion. The article focuses on QSAR and its techniques, HQSAR, several other methods like structural alerts and rule-based models, chemical category and read across model, dose and time response model, virtual ligand screening, docking, 3D pharmacophore mapping, simulation approaches, PKPD models and several other approaches like bioinformatics. After reviewing and studying various in silico techniques the conclusion comes out to be that, in-silico methods of predictive toxicology are more better than in-vitro and in-vivo methods since they are much more safe (as animals are not harmed), economic, fast and accurate w.r.to, results/output in predicting toxicity of compounds by computational methods and hence are widely used in the production of new drug for accessing its toxicity


2018 ◽  
Vol 52 (1) ◽  
pp. 101-109 ◽  
Author(s):  
Praveen Kumar Pasala ◽  
Ramesh Alluri ◽  
Sri Chandana Mavulati ◽  
Raghu Prasad Mailavaram ◽  
Khasim Shaik ◽  
...  

2009 ◽  
Vol 98 (12) ◽  
pp. 4429-4468 ◽  
Author(s):  
Jurgen Mensch ◽  
Julen Oyarzabal ◽  
Claire Mackie ◽  
Patrick Augustijns

Sign in / Sign up

Export Citation Format

Share Document